Table. 10.

Number (%) of participants in the proficiency tests for antibody screening

Trial Specimen No. Negative Positive Intended response
1st BBG-21-01 340 340 (100.0) 0 Negative
BBG-21-02 340 1 (0.3)* 339 (99.7) Positive
BBG-21-03 340 0 340 (100.0) Positive
2nd BBG-21-07 342 2 (0.6)* 340 (99.4) Positive
BBG-21-08 329 342 (100.0) 0 Negative
BBG-21-09 327 340 (99.4) 2 (0.6)* Negative

*Unacceptable responses for antibody screening.

Lab Med Qual Assur 2022;44:10~20 https://doi.org/10.15263/jlmqa.2022.44.1.10
© Lab Med Qual Assur